| Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978) |
|---|
| 01/18/2007 | US20070015745 e.g. 4-[4-(2-hydroxy-3-(4-hydroxy-3-(methylsulphonylamino)phenoxy)propylamino)cyclohexyl]benzoic acid; beta-3 adrenergic receptor agonist; antidiabetic agent, obesity |
| 01/17/2007 | EP1742942A1 Phenylthioacetic acid derivatives and use thereof |
| 01/17/2007 | EP1742927A1 Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof |
| 01/17/2007 | EP1742909A2 Anionic-sweetener-based ionic liquids and methods of use thereof |
| 01/17/2007 | EP1742907A2 Certain chemical entities, compositions, and methods |
| 01/17/2007 | CN1898221A Modulators of atp-binding cassette transporters |
| 01/17/2007 | CN1898219A Novel keto-oxadiazole derivatives as cathepsin inhibitors |
| 01/17/2007 | CN1898218A 1-(azolin-2-yl)amino-1,2-diphenylethane compounds for combatting insects, arachnids and nematodes |
| 01/17/2007 | CN1898196A Method for producing optically active cycloalkylidenebisoxazoline compound and intermediate of the same |
| 01/17/2007 | CN1898190A Process for the preparation of substituted 2-(phenoxymethyl) benzoic acids |
| 01/17/2007 | CN1295221C Substituted heterocyclic compounds |
| 01/16/2007 | US7164043 Conjugate addition reaction between alpha, beta-unsaturated ketone compound and carbamate compound in presence of salt or hydrate salt of transition metal of Groups 7 to 11 of periodic table; high yield and efficiency |
| 01/16/2007 | US7164026 Excellent as a ligand to be used in asymmetric synthesis reactions |
| 01/16/2007 | US7163953 Benzylether derivatives |
| 01/16/2007 | US7163944 Cyclic diamine compound and pharmaceutical containing the same |
| 01/16/2007 | US7163942 Sulfonamide compounds for the treatment of neurodegenerative disorders |
| 01/16/2007 | CA2253453C Alkylaminobenzothiazole and -benzoxazole derivatives |
| 01/11/2007 | WO2007005583A1 Compounds for preparing immunological adjuvant |
| 01/11/2007 | WO2007005572A1 Process for synthesizing a cetp inhibitor |
| 01/11/2007 | WO2007005000A1 Method of synthesis of imidazole-amino acid derivatives and related compounds |
| 01/11/2007 | WO2007004032A1 Oxazolidiones containing cyclobutane as antibacterial agents |
| 01/11/2007 | WO2007003419A1 Heterocyclic compounds as agonists for the thyroid receptor |
| 01/11/2007 | US20070010677 Process for production of piperidine derivatives |
| 01/11/2007 | US20070010563 Novel methods for the treatment of inflammatory diseases |
| 01/11/2007 | DE102004040736B4 Verfahren zur Herstellung von Diarylcycloalkylderivaten A process for preparing Diarylcycloalkylderivaten |
| 01/11/2007 | CA2613962A1 Alkenyldiarylmethanes, fused analogs and syntheses thereof |
| 01/11/2007 | CA2612591A1 Heterocyclic compounds as agonists for the thyroid receptor |
| 01/11/2007 | CA2612142A1 Process for synthesizing a cetp inhibitor |
| 01/11/2007 | CA2611721A1 Compounds for preparing immunological adjuvant |
| 01/10/2007 | EP1741704A1 Method for increasing specific surface area of slightly soluble drug |
| 01/10/2007 | EP1741428A2 Cell adhesion inhibitors |
| 01/10/2007 | EP1740559A1 1,3,5-substituted phenyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease |
| 01/10/2007 | EP1740537A2 A process for the preparation of 2,2-disubstituted pyrroles |
| 01/10/2007 | EP1194147B1 Arylthiazolidinedione and aryloxazolidinedione derivatives |
| 01/10/2007 | CN1894242A Novel oxazolidinone derivatives |
| 01/10/2007 | CN1894235A N-(4-carbamimidoyl-benzyl) -2-alkoxy-2-heterocyclyl acetamides as inhibitors of the formation of coagulation factors xa, ixa and thrombin induced by factor viia |
| 01/10/2007 | CN1893977A Remedies for diseases with bone mass loss having ep4 agonist as the active ingredient. |
| 01/09/2007 | US7160912 Oxazolidinone derivative of the formula (I) or a salt thereof, or a stereoisomer thereof, where R1 represents NHR4 wherein R4 represents thio(C1-C10)acyl, C( . dbd. S)-cyclo(C3-C8)alkoxy, C( .dbd. S) (C1-C10)alkoxy, C( .dbd.S |
| 01/09/2007 | US7160911 Diarylcycloalkyl derivatives, process for their preparation and their use as pharmaceuticals |
| 01/09/2007 | US7160907 Pleuromutilin derivatives |
| 01/09/2007 | US7160903 Sulfonylaminocarboxylic acids |
| 01/09/2007 | CA2144293C Substituted propane derivatives, a process for their preparation and the use of the compounds for treating diseases |
| 01/04/2007 | WO2007002173A1 Hiv-1 protease inhibitors, and methods of making and using them |
| 01/04/2007 | WO2007000235A1 6-oxazol-4-ylmethoxy-alkoxymethyl substituted benzoic acid derivatives forming ppar ligands, methods for production and the use thereof in the form of drugs |
| 01/04/2007 | WO2006069811A3 Compounds that absorb ultraviolet light, methods of their preparation and optical lenses containing them |
| 01/04/2007 | WO2005123050A3 Five-membered heterocycles useful as serine protease inhibitors |
| 01/04/2007 | WO2005012297A9 Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators |
| 01/04/2007 | US20070004784 Oxazole-, oxadiazole- or oxatriazole- functionalized bisarylsulfonamides inhibit the intermediate conductance, calcium activated potassium channel; sickle cell anemia and glaucoma; antiinflammatory, antiproliferative, bronchodilator agents |
| 01/04/2007 | US20070004769 For a novel and efficient synthesis of compounds in which the pharmacophores of quinolone and oxazolidinone are linked to one another by way of a chemically stable linker |
| 01/04/2007 | US20070004751 Substituted heterocyclic compounds |
| 01/04/2007 | US20070004704 Such as 6-Methyl-2-[4-(5-methyl-2-phenyl-oxazol-4-ylmethoxy)-benzenesulfonylamino]-benzoic acid which binds Peroxisome Proliferator-Activated Receptors; conditions in which impaired glucose tolerance, hyperglycemia and insulin resistance are implicated, such as type-1 and type-2 diabetes, and Syndrome X |
| 01/04/2007 | CA2667449A1 Hiv-1 protease inhibitors, and methods of making and using them |
| 01/04/2007 | CA2610074A1 6-oxazol-4-ylmethoxy-alkoxymethyl substituted benzoic acid derivatives forming ppar ligands, methods for production and the use thereof in the form of drugs |
| 01/03/2007 | EP1739082A1 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 01/03/2007 | EP1739081A1 Hydrazino-substituted heterocyclic nitrile compounds and use thereof |
| 01/03/2007 | EP1737850A2 A novel process for the preparation of linezolid and related compounds |
| 01/03/2007 | EP1658273B1 Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide |
| 01/03/2007 | EP0958292B1 4-(3-heterocyclyl-1-benzoyl)pyrazoles and their use as herbicides |
| 01/03/2007 | CN1890226A Oxazole derivatives of tetracyclines |
| 01/03/2007 | CN1889920A Microcapsules with uv filter activity and process for producing them |
| 01/03/2007 | CN1293063C Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 01/03/2007 | CN1293042C Aromatic amino acid derivates and medicinal compositions |
| 01/03/2007 | CN1293034C New gamma selective retinoids |
| 01/02/2007 | US7157487 Vla-4 inhibitors |
| 01/02/2007 | US7157482 Antibacterial 1,3-oxazolidin-2-one derivatives |
| 12/28/2006 | WO2006138328A1 Process for the production of antidiabetic oxazolidinediones |
| 12/28/2006 | WO2006091848A3 Isolated bis-linezolid, preparation thereof, and its use as a reference standard |
| 12/28/2006 | WO2005087752A8 Substituted hydroxyethylamine aspartyl protease inhibitors |
| 12/28/2006 | US20060293536 via non-racemic cinchona-alkaloid-type catalyst (quinidine) for addition of nucleophile |
| 12/28/2006 | US20060293286 Resistant-repellent retroviral protease inhibitors |
| 12/28/2006 | CA2612338A1 Sphingosine kinase inhibitors |
| 12/27/2006 | EP1735319A1 Inhibitors of histone deacetylase |
| 12/27/2006 | EP1735293A2 Substituted hydroxyethylamine aspartyl protease inhibitors |
| 12/27/2006 | EP1735282A1 Pyrazole compounds and uses related thereto |
| 12/27/2006 | EP1735280A1 Aryl sulfonamide and sulfonyl compounds as modulators of ppar and methods of treating metabolic disorders |
| 12/27/2006 | EP1734957A2 Thiazole sulfonamide compounds for the treatment of neurodegenerative disorders |
| 12/27/2006 | EP1654324B1 Sulphonamide anions as catalysts for nco oligomerisation |
| 12/27/2006 | EP1358144B1 Epothilone synthesis components i: asymmetrically substituted acyloins and acyloin derivatives, method for the production thereof and method for the production of epithilone and epothilone derivatives |
| 12/27/2006 | CN1291985C Neurotrophin production/secretion promoting agent |
| 12/27/2006 | CN1291983C Luminescent element material and luminescent element comprising the same |
| 12/27/2006 | CN1291975C New mandelic acid derivatives and their use as thrombase inhibitors |
| 12/27/2006 | CN1291970C Method for preparing combretastatins |
| 12/26/2006 | US7153971 Contacting a carbohydrate with an amine to produce amino tetrahydroxy carbohydrate, protecting two hydroxy groups of tetrahydroxy carbohydrate, forming hydroxy heterocyclic-spiro moiety by reacting with activated carbonate, oxidizing OH |
| 12/26/2006 | US7153889 Alzheimer's disease; antihistamines; attention deficit disorders; hyperactivity; bipolar disorders; cognition activators; psychological disorders; anticancer agents; antidepressants; antiepileptic agents; gastrointestinal disorders ; analgesics |
| 12/26/2006 | US7153878 Substituted thiazoles and oxazoles, e.g., 4-{1-[4-[2-(2-Chloro-6-fluoro-phenyl)-ethyl]-2-(4-trifluoromethyl-phenyl)-thiazol-5-yl]-ethylsulfanyl}-2-methyl-phenoxy)-acetic acid; treating atherosclerosis and diabetes and creating Syndrome X |
| 12/26/2006 | US7153856 Orally administering N-(2-chloro-6-methylphenyl)-2-[4-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-6-ylamino]thiazole-5-carboxamide for treating cancer |
| 12/21/2006 | WO2006134955A1 1, 2-di(cyclic group)substituted benzene derivative |
| 12/21/2006 | WO2006082597A3 Crystal modification of 5-substituted-2-oxazoiidone derivative and its process thereof |
| 12/21/2006 | WO2006069154A3 Vitamin d receptor modulators |
| 12/21/2006 | WO2006047438A3 Insecticidal 3-(dihaloalkenyl) phenyl derivatives |
| 12/21/2006 | WO2006021420A3 Method for the production of diarylcycloalkyl derivatives |
| 12/21/2006 | WO2005072376A3 Anionic-sweetener-based ionic liquids and methods of use thereof |
| 12/21/2006 | US20060287534 Method of obtaining urethane-protected n-carboxyanhydrides of alpha amino acids |
| 12/21/2006 | US20060287396 4-aryl quinols and analogs thereof as therapeutic agents |
| 12/21/2006 | US20060287376 2-bromoaniline and 2-chloroaniline derivatives; used to make indole compounds |
| 12/21/2006 | US20060287304 Dihydronaphthalene derivative compounds and agent comprising the derivative as active ingredient |
| 12/21/2006 | DE102005029382B3 New alkoxymethylyl substituted benzoic acid derivatives are peroxisome proliferation activated receptor agonists used for treating and/or preventing e.g. diabetes mellitus, dyslipidemia and disturbances in fatty acid metabolism |
| 12/21/2006 | DE102004061037B4 Oxazolinmischung Oxazolinmischung |
| 12/21/2006 | CA2607054A1 1, 2-di(cyclic group)substituted benzene derivative |
| 12/20/2006 | EP1732884A1 Sulphonamide derivatives |